Gong L - Search Results

1

Atractylenolide III predisposes miR-195-5p/FGFR1 signaling axis to exert tumor-suppressive functions in liver cancer.

Sheng L, Li J, Li N, Gong L, Liu L, Zhang Q, Li X, Luo H, Chen Z. Sheng L, et al. Among authors: gong l. J Food Biochem. 2021 May;45(5):e13582. doi: 10.1111/jfbc.13582. Epub 2021 Mar 26. J Food Biochem. 2021. PMID: 33768570

2

Glycolysis in Panc-1 human pancreatic cancer cells is inhibited by everolimus.

Liu L, Gong L, Zhang Y, Li N. Liu L, et al. Among authors: gong l. Exp Ther Med. 2013 Jan;5(1):338-342. doi: 10.3892/etm.2012.787. Epub 2012 Nov 1. Exp Ther Med. 2013. PMID: 23251295 Free PMC article.

3

Biliary Cast Syndrome: Hepatic Artery Resistance Index, Pathological Changes, Morphology and Endoscopic Therapy.

Tian H, Liao QD, Li NF, Peng J, Gong LS, Liu J. Tian H, et al. Chin Med J (Engl). 2015 Jul 20;128(14):1910-5. doi: 10.4103/0366-6999.160537. Chin Med J (Engl). 2015. PMID: 26168832 Free PMC article.

4

Bisphenol A regulates Snail-mediated epithelial-mesenchymal transition in hemangioma cells.

Zhai D, He J, Li X, Gong L, Ouyang Y. Zhai D, et al. Among authors: gong l. Cell Biochem Funct. 2016 Aug;34(6):441-8. doi: 10.1002/cbf.3206. Epub 2016 Aug 2. Cell Biochem Funct. 2016. PMID: 27480627

5

Overexpression of microRNA-497 suppresses cell proliferation and induces apoptosis through targeting paired box 2 in human ovarian cancer.

Lin Z, Zhao J, Wang X, Zhu X, Gong L. Lin Z, et al. Among authors: gong l. Oncol Rep. 2016 Oct;36(4):2101-7. doi: 10.3892/or.2016.5012. Epub 2016 Aug 11. Oncol Rep. 2016. PMID: 27513319

6

MiR-590-3p suppresses hepatocellular carcinoma growth by targeting TEAD1.

Ge X, Gong L. Ge X, et al. Among authors: gong l. Tumour Biol. 2017 Mar;39(3):1010428317695947. doi: 10.1177/1010428317695947. Tumour Biol. 2017. PMID: 28349829 Free article.

7

Galangin (GG) combined with cisplatin (DDP) to suppress human lung cancer by inhibition of STAT3-regulated NF-κB and Bcl-2/Bax signaling pathways.

Yu S, Gong LS, Li NF, Pan YF, Zhang L. Yu S, et al. Among authors: gong ls. Biomed Pharmacother. 2018 Jan;97:213-224. doi: 10.1016/j.biopha.2017.10.059. Epub 2017 Nov 6. Biomed Pharmacother. 2018. PMID: 29091869

8

Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype.

Xiao Y, Sun Y, Liu G, Zhao J, Gao Y, Yeh S, Gong L, Chang C. Xiao Y, et al. Among authors: gong l. Cancer Lett. 2019 Mar 1;444:175-187. doi: 10.1016/j.canlet.2018.11.004. Epub 2018 Nov 15. Cancer Lett. 2019. PMID: 30448543

9

Targeting the estrogen receptor alpha (ERα)-mediated circ-SMG1.72/miR-141-3p/Gelsolin signaling to better suppress the HCC cell invasion.

Xiao Y, Liu G, Sun Y, Gao Y, Ouyang X, Chang C, Gong L, Yeh S. Xiao Y, et al. Among authors: gong l. Oncogene. 2020 Mar;39(12):2493-2508. doi: 10.1038/s41388-019-1150-6. Epub 2020 Jan 29. Oncogene. 2020. PMID: 31996784

10

Loss of androgen receptor promotes HCC invasion and metastasis via activating circ-LNPEP/miR-532-3p/RAB9A signal under hypoxia.

Ouyang X, Yao L, Liu G, Liu S, Gong L, Xiao Y. Ouyang X, et al. Among authors: gong l. Biochem Biophys Res Commun. 2021 Jun 11;557:26-32. doi: 10.1016/j.bbrc.2021.02.120. Epub 2021 Apr 13. Biochem Biophys Res Commun. 2021. PMID: 33862456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,071 results

Search Page

Filters